UroGen Pharma Ltd. (URGN) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading URGN…

UroGen Pharma Ltd. (URGN) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

UroGen Pharma Ltd.

URGN · CIK 1668243

4 · Aug 24, 2026 · Chief Medical Officer Schoenberg Mark sold 60.68K shares at $47.05/share ($2.9M)

4

Chief Medical Officer Schoenberg Mark sold 60.68K shares at $47.05/share ($2.9M)

Filed: Aug 24, 2026
Period: Aug 20, 2026
Accession: 0001437749-26-028840
Filer: UroGen Pharma Ltd.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4rdgdoc.xml
Open SEC.gov